- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin glulisine, Insulin glargine
Total 2788 results
-
SanofiCompletedDiabetes Mellitus, Type 1France
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiTerminatedAMICanada, Brazil, United States, Argentina, Mexico
-
SanofiTerminatedDiabetes Mellitus, Type 2Brazil
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
SanofiCompletedDiabetes Mellitus, Type 1Bahrain, Kuwait, Qatar, United Arab Emirates
-
HaEmek Medical Center, IsraelCompletedDiabetes Mellitus Type 2
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Austria, United Arab Emirates, Spain, Romania, Colombia, Korea, Republic of, Brazil, Greece, Italy, China, Denmark, India, Kuwait, Mexico, Taiwan, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 1Belarus
-
SanofiCompletedInsulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinDiabetes Mellitus, Type 2United States
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentUnknownInsulin-requiring Type 2 Diabetes MellitusGermany
-
Emory UniversitySanofi; University of MiamiCompletedHyperglycemia | DiabetesUnited States
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Brazil, Israel, Lebanon, Mexico, Morocco, Peru, Saudi Arabia, United Arab Emirates, Venezuela
-
SanofiCompletedDiabetes Mellitus, Type 2France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
Emory UniversitySanofiCompletedDiabetic KetoacidosisUnited States
-
IKFE Institute for Clinical Research and DevelopmentCompleted
-
Universidad Nacional de AsunciónCompletedHyperglycemia | DiabetesParaguay
-
SanofiCompletedDiabetes Mellitus, Type 1Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
-
SanofiTerminated
-
SanofiCompletedDiabetes MellitusChina
-
Guillermo Umpierrez, MDMedical University of South Carolina; Sanofi; Texas A&M UniversityCompletedHyperglycemia | Type 2 DiabetesUnited States
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
Population Health Research InstituteCompletedHyperglycemia | Myocardial Infarction | Cardiovascular DiseasesArgentina, Canada, India
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusChina
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
Emory UniversitySanofiCompletedType 2 Diabetes | Inpatient HyperglycemiaUnited States
-
SanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
Rabin Medical CenterSanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
Cairo UniversityCompletedDiabetes Mellitus (DM)Egypt